Novartis shares jump on improved outlook
AFP · 22 Oct 2013, 18:29
Published: 22 Oct 2013 18:29 GMT+02:00
- Customs seize crates of fake anti-anxiety drugs (18 Oct 13)
- Roche head talks up Novartis 'relationship' (01 Oct 13)
- Japan to raid Novartis over 'fake data': reports (27 Sep 13)
Earlier this year, Novartis forecast a significant blow to earnings from the arrival of generic versions of a best-selling drug but, hit by delays, the threat has yet to materialize.
In the third quarter, the drugs company saw sales rise by four percent to $14.3 billion while net profit fell by six percent to $2.26 billion.
On the Zurich stock market, which was up 0.65 percent overall in afternoon trading, Novartis shares were showing a gain of 1.69 percent to 69.10 francs.